Eli Lilly Pharmaceutical Company

853 Words3 Pages
Eli Lilly & Co. lost a group of important select patents so they are now looking to compete by producing new drugs . Due to long research and development times prior to a drug hitting the market, revenue forecasts for the company are unknown. Lilly’s short-term forecast is not much clearer as “revenue for the fourth quarter of 2013 declined 2 percent to $5.80 billion largely on Cymbalta’s patent expiration, the company affirmed. Net income dropped 12 percent to $727.5 million, or 67 cents per diluted share, compared with $827.2 million, or 74 cents per share, for the year-earlier quarter” (Zhang).
Lilly’s unique proficiency is its capability to bring about drug advancement. Lilly has the skill to identify prospective drug applicants by frequently improving processes with their research and development. To give an example, in the 1960s Lilly started a line of oral and injectable antibiotics called cephalosporins. Lilly has many examples such as this in which they are the first company to do XY or Z. The company is continually investing in new alliances and technologies around the world to aid in their research and to expand their abilities. The company will be able to achieve further patents as a result of their new alliances and technology research. Eli Lilly’s main focal points are quality, innovation, and customer care. With a focus on the not yet met medical needs of clients, the response time in which they deliver important drug therapies hit the market, and top
Get Access